IDEAYA Biosciences, Inc.IDYANASDAQ

Revenue (LTM)

$219M

+3024.4% YoY

Net Income (LTM)

$-114M

+58.6% YoY

Free Cash Flow

$-73M

Revenue CAGR (5Y)

+67.3%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	28	51↑82.3%	23↓54.1%	7↓70.1%	219↑3024.4%
Gross Profit	26	49↑86.3%	19↓60.3%	3↓83.7%	214↑6663.0%
Operating Income	-50	-63↓24.3%	-134↓115.1%	-327↓143.2%	-159↑51.3%
Net Income	-50	-59↓17.9%	-113↓92.6%	-274↓143.0%	-114↑58.6%
EBITDA	-48	-57↓17.7%	-109↓92.7%	-271↓148.4%	-155↑42.8%
EPS Diluted	-1.41	-1.42↓0.7%	-1.96↓38.0%	-3.36↓71.4%	-1.28↑61.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	92	69↓25.4%	157↑128.8%	84↓46.3%	113↑33.7%
Total Current Assets	251	370↑47.6%	533↑43.8%	690↑29.5%	667↓3.3%
Total Assets	381	388↑1.7%	649↑67.4%	1,124↑73.1%	1,109↓1.3%
Total Current Liabilities	45	32↓29.8%	27↓14.6%	46↑70.0%	59↑27.7%
Total Liabilities	80	39↓51.8%	28↓26.7%	65↑130.1%	86↑33.0%
Total Equity	302	349↑15.9%	621↑77.7%	1,059↑70.5%	1,023↓3.4%
Total Debt	5	3↓32.8%	3↓17.5%	19↑567.5%	28↑45.6%
Net Debt	-87	-65↑25.0%	-154↓136.6%	-65↑57.7%	-85↓30.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-56	-87↓56.3%	-115↓32.2%	-248↓114.9%	-71↑71.3%
Capital Expenditure	-3	-3↓30.2%	-2↑31.2%	-4↓62.9%	-2↑38.6%
Free Cash Flow	-58	-91↓55.1%	-118↓29.8%	-251↓113.8%	-73↑70.8%
Stock-Based Comp	8	12↑41.2%	18↑59.0%	35↑87.9%	0
Net Change in Cash	20	-23↓217.0%	89↑480.3%	-73↓181.5%	28↑139.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance